View of Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies.

Return to Article Details Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies. Download Download PDF